Immorta Bio's Innovative Therapy Doubles Mouse Lifespan: A New Era in Longevity Science Discover how Immorta Bio has achieved a groundbreaking milestone by doubling the lifespan of mice through a novel combination of therapies in aging research.

Immorta Bio's Innovative Therapy Doubles Mouse Lifespan: A New Era in Longevity Science #USA #San_Francisco #Immorta_Bio #SenoVax #StemCellRevivify

Immorta Bio's SenoVax™ Triumphs in Reducing Solid Tumors Across Multiple Cancer Types Immorta Bio has made significant strides in cancer treatment with SenoVax™, which shows promise in reducing tumors in lung, brain, pancreatic, and breast cancers, marking a potential shift in immunotherapy.

Immorta Bio's SenoVax™ Triumphs in Reducing Solid Tumors Across Multiple Cancer Types #USA #Miami #Cancer_Treatment #Immorta_Bio #SenoVax

Immorta Bio Launches International Patent for SenoVax™, Redefining Cancer Treatment and Aging Therapies Immorta Bio has unveiled a groundbreaking patent application for SenoVax™, an innovative immunotherapy aimed at combating aging and cancer. This first-of-its-kind approach targets senescent cells.

Immorta Bio Launches International Patent for SenoVax™, Redefining Cancer Treatment and Aging Therapies #USA #Miami_Beach #Immorta_Bio #SenoVax #mRNA_Therapy

Immorta Bio Innovates with New StemCellRevivify™ Platform for Aging Regeneration Immorta Bio has unveiled its StemCellRevivify™ platform aimed at regenerating heart, brain, and liver tissues using youthful mitochondria. This breakthrough could change aging treatments.

Immorta Bio Innovates with New StemCellRevivify™ Platform for Aging Regeneration #United_States #Miami_Beach #Immorta_Bio #SenoVax #StemCellRevivify

Immorta Bio Unveils Revolutionary Method to Awaken Comatose Patients through Innovative Therapy Immorta Bio's recent research publication outlines a groundbreaking approach to revive coma patients using senolytic immunotherapy and stem cells, marking a significant advancement in medical science.

Immorta Bio Unveils Revolutionary Method to Awaken Comatose Patients through Innovative Therapy #USA #Miami #Immorta_Bio #SenoVax #StemCellRevivify

Dr. Gilberto Lopes Joins Immorta Bio: A Leap into Longevity and Cancer Treatment Renowned lung cancer expert Dr. Gilberto Lopes has joined Immorta Bio's Strategic Advisory Board to advance longevity therapies and immunoncology.

Dr. Gilberto Lopes Joins Immorta Bio: A Leap into Longevity and Cancer Treatment #USA #Miami #Immorta_Bio #SenoVax #Gilberto_Lopes

Immorta Bio to Unveil SenoVax™ Cancer Therapy Findings at AAI Annual Meeting Immorta Bio Inc will present groundbreaking preclinical data on its SenoVax™ immunotherapy for cancer at the AAI Annual Meeting, advancing longevity science.

Immorta Bio to Unveil SenoVax™ Cancer Therapy Findings at AAI Annual Meeting #USA #Miami #cancer_therapy #Immorta_Bio #SenoVax

Immorta Bio's Innovative Research for Enhancing Immune Response Against Cancer and Viruses Immorta Bio's latest study reveals how removing senescent cells boosts natural killer cells, potentially transforming cancer therapies and immune responses.

Immorta Bio's Innovative Research for Enhancing Immune Response Against Cancer and Viruses #USA #Miami #Immorta_Bio #SenoVax #Natural_Killer_Cells

Immorta Bio Unveils Groundbreaking SenoVax Product at Cancer Immunotherapy Symposium Immorta Bio will showcase innovative data on its SenoVax senolytic product aimed at treating various cancers at the upcoming SITC Symposium in San Diego.

Immorta Bio Unveils Groundbreaking SenoVax Product at Cancer Immunotherapy Symposium #USA #San_Diego #Cancer_Immunotherapy #Immorta_Bio #SenoVax

Immorta Bio to Share Cutting-Edge Longevity Solutions at Biotech Showcase 2025 Immorta Bio will unveil significant advancements in longevity biotechnologies, including SenoVax™ and StemCell Revivify™, at Biotech Showcase 2025.

Immorta Bio to Share Cutting-Edge Longevity Solutions at Biotech Showcase 2025 #United_States #San_Francisco #Immorta_Bio #SenoVax #StemCell_Revivify